Quality improvement exercises in Inflammatory Bowel Disease (IBD) services: A scoping review
- PMID: 38451904
- PMCID: PMC10919633
- DOI: 10.1371/journal.pone.0298374
Quality improvement exercises in Inflammatory Bowel Disease (IBD) services: A scoping review
Abstract
Objective: Quality Improvement initiatives aim to improve care in Inflammatory Bowel Disease (IBD). These address a range of aspects of care including adherence to published guidelines. The objectives of this review were to document the scope and quality of published quality improvement initiatives in IBD, highlight successful interventions and the outcomes achieved.
Design/method: We searched MEDLINE, EMBASE, CINAHL and Web of Science. Two reviewers independently screened and extracted data. We included peer reviewed articles or conference proceedings reporting initiatives intended to improve the quality of IBD care, with both baseline and prospectively collected follow-up data. Initiatives were categorised based on problems, interventions and outcomes. We used the Quality Improvement Minimum Quality Criteria Set instrument to appraise articles. We mapped the focus of the articles to the six domains of the IBD standards.
Results: 100 studies were identified (35 full text; 65 conference abstracts). Many focused on vaccination, medication, screening, or meeting multiple quality measures. Common interventions included provider education, the development of new service protocols, or enhancements to the electronic medical records. Studies principally focused on areas covered by the IBD standards 'ongoing care' and 'the IBD service', with less focus on standards 'pre-diagnosis', 'newly diagnosed', 'flare management', 'surgery' or 'inpatient care'.
Conclusion: Good quality evidence exists on approaches to improve the quality of a narrow range of IBD service functions, but there are many topic areas with little or no published quality improvement initiatives. We highlight successful quality improvement interventions and offer recommendations to improve reporting of future studies.
Copyright: © 2024 Ridsdale et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
I have read the journal’s policy and the authors of this manuscript have the following competing interests: Professor Alan Lobo has acted as a consultant and advisory board member for Takeda Pharma, Janssen and Bristol Myers Squibb. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Figures
References
-
- Alatab S, Sepanlou SG, Ikuta K, Vahedi H, Bisignano C, Safiri S, et al.. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17–30. doi: 10.1016/S2468-1253(19)30333-4 - DOI - PMC - PubMed
-
- IBD Standards. IBD UK [Internet]. [cited 2022 Aug 17]; Available from: https://ibduk.org/ibd-standards
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
